HemoCue

EQT II bought HemoCue in 1999 from Mallinckrodt Inc.

For more than 10 years, HemoCue had been a recognized global leader in professional diagnostics point-of-care testing. The product strategies behind HemoCue's success where based on a clear focus on important diagnostic tests of the highest quality, which was fast and easy to perform by anyone.

EQT II sold HemoCue in 2007 to Quest Diagnostics.

Key events during EQT's ownership

New Management and “revitalized” vision and growth strategy

Business realignment in Product Business Units with clear performance criteria and expectations

Fast facts

EQT II B.V. (“EQT”) has sold HemoCue, a leading point-of-care diagnostic testing company, to Quest Diagnostics. EQT acquired HemoCue in December 1999 from Mallinckrodt, Inc. and has since substantially developed and reshaped the business. Following the acquisition, a strategic shift was made to...